Regulations.gov document
Enzymatic Therapy, Inc. - Sweet Defense - maintain fasting glucose and triglyceride levels…
Other · FDA-1997-S-0039 · posted Mar 28, 2016
Key facts
| Document ID | FDA-1997-S-0039-0882 |
|---|---|
| Title | Enzymatic Therapy, Inc. - Sweet Defense - maintain fasting glucose and triglyceride levels already within the normal range |
| Document type | Other |
| Subtype | 30 Day Structured Function Claim |
| Agency | FDA |
| Docket | FDA-1997-S-0039 |
| Posted | Mar 28, 2016 |
| Comment period opens | Mar 28, 2016 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: